Company Overview and News

2
SEC Fines SeaWorld & Ex-CEO for Hiding 'Blackfish' Impact

4h zacks
Orlando-based marine theme park operator SeaWorld Entertainment, Inc. (SEAS - Free Report) and its former chief executive has been slapped $5 million in fines by the Securities and Exchange Commission or SEC for not disclosing the negative impact a documentary film “Blackfish” was having on its business. The documentary focused on how the treatment of orcas led to the death of trainers. As per the recent SEC filing, an agreement between the company and the SEC has been made to settle the claim.
SEAS ELY RDIB MTN RDI

13
Camping World Holdings (CWH) Surges: Stock Moves 6.8% Higher

2018-09-18 zacks
Camping World Holdings, Inc. (CWH - Free Report) was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $19.03 to $21.05 in the past one-month time frame.
CWH RDIB MDPEB RDI MDP

2
Royal Caribbean Stock Up 13% in 3 Months: More Room to Run?

2018-09-17 zacks
Higher passenger ticket, increasing demand for cruises, solid booking trends and technological investment bode well for Royal Caribbean Cruises Ltd. (RCL - Free Report) . In the past three months, the stock has gained 12.8% compared with the industry’s 3.4% growth. However, higher costs might hurt the company’s profitability in the near term. Let’s delve deeper.
RDIB CUKPF MTN CCL RDI RCL CCL CUK

6
Madison Square (MSG) Rises 23% in 6 Months: More Room to Run?

2018-08-28 zacks
The past six months have been rewarding for The Madison Square Garden Company (MSG - Free Report) . The stock has gained 23.7% against the industry’s 1.1% decline. This outperformance can be primarily attributed to solid brand presence and strong entertainment business.
SEAS CHTR MSG RDIB MTN RDI DAL

1
Cinema stocks tumble after report Amazon in the running to acquire Landmark Theatres - MarketWatch

2018-08-16 marketwatch
Cinema stocks tumbled in premarket trade Thursday morning after Bloomberg reported that e-commerce giant Amazon.com Inc. AMZN, +0.97% is looking to acquire theater chain Landmark Theatres.
RDIB AMC RDI CNK

 
Independent Bank Sees Hammer Chart Pattern: Time to Buy?

2018-08-10 zacks
Independent Bank Corporation (IBCP - Free Report) has been struggling lately, but the selling pressure may be coming to an end soon. That is because IBCP recently saw a Hammer Chart Pattern which can signal that the stock is nearing a bottom.
IBCP GD RDIB PVG IBTX RDI PVG INDB

8
Northern Oil and Gas Sees Hammer Chart Pattern: Time to Buy?

2018-08-10 zacks
Northern Oil and Gas, Inc. (NOG - Free Report) has been struggling lately, but the selling pressure may be coming to an end soon. That is because NOG recently saw a Hammer Chart Pattern which can signal that the stock is nearing a bottom.
GD RDIB PVG NOG RDI PVG

 
Histogenics Sees Hammer Chart Pattern: Time to Buy?

2018-08-10 zacks
Histogenics Corporation (HSGX - Free Report) has been struggling lately, but the selling pressure may be coming to an end soon. That is because HSGX recently saw a Hammer Chart Pattern which can signal that the stock is nearing a bottom.
GD RDIB PVG HSGX RDI PVG

 
Reading International (RDI) Q2 Earnings Surpass Estimates

2018-08-10 zacks
Reading International (RDI - Free Report) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.29 per share a year ago. These figures are adjusted for non-recurring items.
GD RDIB UNIT RDI

116
Tracking Yacktman Asset Management Portfolio - Q2 2018 Update

2018-08-06 seekingalpha - 2
Yacktman Asset Management decreased Twenty-First Century Fox, Microsoft, Sysco, and Cisco Systems substantially during the quarter.
ATHTF SYY XOM ULVR AVP RDI CHRW UNLNF UHAL SYK CSCO CMCSK ABBV HSY MO CRMT FOX GLW BAC HSYFB NWS NWSA UNLYF INFY BRK.A JNJ BK INFY ABBV MSFT CLX FOXA WFCNP PG CCV CCZ BAC COP OTEL PM RDIB NWS KO ORCL DIS WFC GJV UL UN CMCSA ANTM PEP CCV.CL OCLCF ANTX

679
Stocks To Watch: FANGs Out In Tech

2018-07-21 seekingalpha - 4
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
YUM AROC TCAP HYRE ABT CRM BXS BHC CHFC RGA CSCO TBIO UXIN CAH PKD MS HSY GWP SNAP NCMI FOX JCOM HOMB AMC GILD MNLO UTX SYF MDT CYS EXPE ACB GWPH EMHTF JNJ ALV VZ APHQF VNE LMT FB OLED STIM NFLX BAX EHC SKX BAC ZION OKE.WI CL FPBK TCCB OKE TCCA INTC AGS CBS UL WYNN EVER MA GSK FNSR TCDA UA FFKT NTGN HAS FNKO SBUX CAKE APTV TXN TBQBF XOM ACBFF TWX UAA RF RDI IMAX CNK GTES AMZN TWTR HMNY TWO EBAY BBT ARMO BAC CMA EYEN CRON BV TCC MDLZ CMG PFS BJ GOOGL LVS QCOM FOXA PFE LOVE WFCNP HAL PM HRB WWW GPC PYPL PAGS DLPH MCS PFG TWMJF RDIB AMCX WEED ACN DIS MCD ABT WFC QRVO MJN F SLDB BRY CMCSA K CGC SNPS EMH T MRK CVX FTSV SNE LITE MEDFF PZZA TILE

564
Tracking Yacktman Asset Management Portfolio - Q1 2018 Update

2018-05-10 seekingalpha - 3
This article is part of a series that provides an ongoing analysis of the changes made to Yacktman's 13F stock portfolio on a quarterly basis. It is based on Yacktman Asset Management's regulatory 13F Form filed on 05/09/2018. Please visit our Tracking Yacktman Asset Management series to get an idea of his investment philosophy and our previous update for the fund's moves during Q4 2017.
ATHTF SYY XOM ULVR AVP RDI CHRW UNLNF HPE UHAL VIAB SYK CSCO CMCSK ABBV MMM CRMT MO FOX STT GLW NWS NWSA UNLYF INFY CTSH BRK.A JNJ BK MSFT ABBV CLX FOXA ESRX WFCNP PM MTSI PG CCV CCZ USB COP BAC GS OTEL RDIB PM NWS KO ORCL DIS WFC GJV UL UN CMCSA ANTM PEP CCV.CL OCLCF HPQ ANTX

1080
Stocks To Watch: Apple, FOMC And China On Tap

2018-04-28 seekingalpha - 2
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
YUM PSX UAA RDI LOMA CNK AQ ALTR 1128 FEYE AMT JNPR 1928 CAH AKAO VLKAY HX SNAP NAOV CARAF SPRO AMC GILD TMUS MDR PCAR SSLJ CMG OA MAR AQUA GPRO EXPD BABA CZR FLL FCAU SJMHF PFE FB FIT TM CSV GOOG BAX RRR ATVI MCS MAR.WI SJMHY SSD MLCO RDIB AGN ALNA AAPL CCI GM BIDU MCD DIS CBS F WYNN FISOF SCHYF MA WYNMF HMC 0880 ACMR UA BHI TSCO S 506186 PEP GLXYENT FNKO TSLA MNK CBI SBAC SCHYY BYD WYNMY

1534
Stocks To Watch: Earnings Blockbusters And Trump Talks Drug Prices

2018-04-21 seekingalpha - 1
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
VR GIS CAT PSX TEVA FSCT FIXX ZNGA WYN MS MMP ABBV UMRX AMGN AMC TRV BILI UNUM DVMT CZR JNJ GHG VZ MSFT HBI ALDR MGM DVD FB EPD ZION VRX AGN CL KO INTC WYNN LLY GSK AVY NEXA NXP MU GNPX KHC SBUX LQ LM BYD IVZ MBIN TXN XOM TWX RDI IPIC CNK AMZN TWTR GSK VLKAY EBAY NBL VRX LMHA PCAR KMB AIG TWC LMHB CMG NAV GOOGL IONS ABBV PTCT LVS QCOM BA FOXA PFE HAL XLNX EYE ETH RRR VMW MCS CHTR RDIB BIIB GWW GM PAA DAL LAD DIS BMY MBNC IBM MPLX ALKS CMCSA FTI.WI FMC V NAVI PEP T IQ MRK CVX SNE HPQ BPMP

2
BRIEF-Appeals Court Halts Appointment Of Trustee To Market Reading International Voting Stock

2018-04-16 reuters
* READING INTERNATIONAL INC - CALIFORNIA COURT OF APPEALS HAS STAYED ALL TRIAL COURT PROCEEDINGS AND ISSUED AN ORDER TO SHOW CAUSE Source text for Eikon: Further company coverage:
RDIB RDI

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

CUSIP: 755408101